Latest news
Loading news…
MyoGene Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Los Angeles, California, United States Founded 2018 1-10 employees For Profit
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $18K
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 4
- HQ
- Los Angeles, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.3
- Trend (30d)
- -0.3
- Trend (90d)
- -0.4
3
professional contacts at MyoGene Bio
Contact execs at MyoGene Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to MyoGene Bio
Loading news…
FAQs about MyoGene Bio
People who checked this page also checked these
Browse the full Acquirezy directory.